The Financial Express54m
Vedanta Q3 Results: Profit surges by 70.01% to Rs 4,876 crore, posts highest ever Q3 EBITDA at Rs 11,284 crore
Vedanta reported revenue from operations at Rs 38,526 crore, up 10.18 per cent as against Rs 34,968 crore during the same ...
Vedanta gains after Q3 PAT rises 70% YoY to Rs 4,876 cr
Vedanta added 1.91% to Rs 440.50 after the company's consolidated net profit jumped 70.01% to Rs 4,876 crore in Q3 FY25 as compared with Rs 2,868 crore in Q3 FY24.
Sun Pharma Q3 Results: PAT advances 15% YoY to Rs 2,903 crore, beats estimates
Results: The company has also declared an interim dividend of Rs 10.5 per share for the financial year 2024-25.
Sun Pharma announces Rs 10.50/share interim dividend, sets Feb 6 as record date
The company set February 6, 2025, as the record date for the dividend, payable by February 20, 2025. The company announced the dividend alongside its Q3 earnings, reporting a 15% YoY rise in net ...